Provenge vaccine boosts survival for men with prostate cancer
News about Provenge vaccine … getting closer:
Provenge prostate cancer vaccine linked to longer survival for asymptomatic hormone refractory stage — UCSF study. June 28, 2006.
Dendreon Announces Publication of Pivotal Phase 3 Study Highlighting Survival Benefit and Safety Profile of PROVENGE in Men with Advanced Prostate Cancer June 29, 2006
Dendreon Announces FDA Grants Fast Track Status for Provenge
No Comments
You must be logged in to post a comment.